Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

RA Larson, EL Sievers, EA Stadtmauer, Bob Löwenberg, EH Estey, H Dombret, M Theobald, D Voliotis, JM Bennett, M Richie, LH Leopold, MS Berger, ML Sherman, MR Loken, Jacques Dongen, ID Bernstein, FR Appelbaum

Research output: Contribution to journalArticleAcademicpeer-review

392 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1442-1452
Number of pages11
Issue number7
Publication statusPublished - 2005

Research programs

  • EMC MM-02-41-03
  • EMC MM-02-72-03

Cite this